These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 17064808)
21. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006. Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378 [TBL] [Abstract][Full Text] [Related]
22. Waist circumference as a cardiovascular and metabolic risk in Japanese patients with type 2 diabetes. Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Ishibashi S; Oikawa S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N Obesity (Silver Spring); 2009 Mar; 17(3):585-92. PubMed ID: 19023281 [TBL] [Abstract][Full Text] [Related]
23. UKPDS-modelling of cardiovascular risk assessment and lifetime simulation of outcomes. Adler AI Diabet Med; 2008 Aug; 25 Suppl 2():41-6. PubMed ID: 18717978 [TBL] [Abstract][Full Text] [Related]
24. The relationship between resting heart rate and atherosclerosis risk factors. Piwońska A; Piotrowski W; Broda G; Drygas W; Głuszek J; Zdrojewski T; Kozakiewicz K; Stepaniak U; Bandosz P Kardiol Pol; 2008 Oct; 66(10):1069-75; discussion 1076-8. PubMed ID: 19006028 [TBL] [Abstract][Full Text] [Related]
25. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening. Sinclair G; Kerr A N Z Med J; 2006 Nov; 119(1245):U2312. PubMed ID: 17146487 [TBL] [Abstract][Full Text] [Related]
26. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Kanjilal S; Gregg EW; Cheng YJ; Zhang P; Nelson DE; Mensah G; Beckles GL Arch Intern Med; 2006 Nov; 166(21):2348-55. PubMed ID: 17130388 [TBL] [Abstract][Full Text] [Related]
27. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Unnikrishnan RI; Rema M; Pradeepa R; Deepa M; Shanthirani CS; Deepa R; Mohan V Diabetes Care; 2007 Aug; 30(8):2019-24. PubMed ID: 17488949 [TBL] [Abstract][Full Text] [Related]
28. The quantification of cardiovascular risk factors in subjects with/without diabetes mellitus. Pănuş C; Răducanu CL; Mota M Rom J Intern Med; 2004; 42(2):355-70. PubMed ID: 15529626 [TBL] [Abstract][Full Text] [Related]
29. Type-2 diabetes mellitus related cardiovascular risk: new options for interventions to reduce risk and treatment goals. Hobbs FD Atheroscler Suppl; 2006 Aug; 7(4):29-32. PubMed ID: 16822723 [TBL] [Abstract][Full Text] [Related]
30. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study. Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689 [TBL] [Abstract][Full Text] [Related]
31. Combining population health and baseline risk strategy by determining an age cutoff for initiating statins in patients with diabetes: a population-based study. Siyambalapitiya S; Bulugahapitiya U; Sithole J; Song S; Fernando DJ; Idris I Diabetes Care; 2007 Aug; 30(8):2025-9. PubMed ID: 17519429 [TBL] [Abstract][Full Text] [Related]
32. [Epidemiologic study of diabetic retinopathy in a primary care unit]. Romero Aroca P ; Calviño Domínguez O ; Del Castillo Dejàrdin D Arch Soc Esp Oftalmol; 2000 Mar; 75(3):147-52. PubMed ID: 11151141 [TBL] [Abstract][Full Text] [Related]
33. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study. Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y; Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Yokoyama H; Sone H; Oishi M; Kawai K; Fukumoto Y; Kobayashi M; Nephrol Dial Transplant; 2009 Apr; 24(4):1212-9. PubMed ID: 18984626 [TBL] [Abstract][Full Text] [Related]
35. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study. Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803 [TBL] [Abstract][Full Text] [Related]
36. Treatment of hypertension in patients with diabetes. Sowers JR Arch Intern Med; 2004 Sep; 164(17):1850-7. PubMed ID: 15451759 [TBL] [Abstract][Full Text] [Related]
37. Management of type 2 diabetes mellitus: is it in accordance with the guidelines? Chan GC; Ghazali O; Khoo EM Med J Malaysia; 2005 Dec; 60(5):578-84. PubMed ID: 16515108 [TBL] [Abstract][Full Text] [Related]
38. The association between erectile dysfunction and cardiovascular risk in men with Type 2 diabetes in primary care: it is a matter of age. Cleveringa FG; Meulenberg MG; Gorter KJ; van den Donk M; Rutten GE J Diabetes Complications; 2009; 23(3):153-9. PubMed ID: 18413203 [TBL] [Abstract][Full Text] [Related]
39. Coronary heart disease and cardiovascular risk factors among people aged 25-65 years, as seen in Romanian primary healthcare. Bunescu DM; Stoffers HE; van den Akker M; Jan Dinant G Eur J Gen Pract; 2008; 14(2):56-64. PubMed ID: 18720274 [TBL] [Abstract][Full Text] [Related]
40. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?]. Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]